Donald Rucker breaks down what the proposed rule actually changes: FHIR protocol requirements shifting from advisory to mandatory, prior authorization extending to drugs across two parallel pathways (Da Vinci FHIR for medical benefit drugs, NCPDP for pharmacy benefit), and a new National Healthcare Directory reporting requirement that gives CMS a practical compliance enforcement mechanism for the first time
May your medications stay properly dosed, your monitoring stay consistent, and your weight loss journey stay safe.
The peptide market is, frankly, sprawling and inconsistent
Timing your weekly injection Consistency matters more than the specific day or time you choose
This FDA-approved therapy helps reduce pain, improve mobility, and delay or potentially avoid the need for knee replacement surgery in patients with osteoarthritis [1]
Only if the weight loss is prescribed to treat a documented medical condition, such as clinical obesity with a comorbidity, cardiovascular disease, or hypertension